Autocrine c-met/HGF HCC patient derived xenograft (PDX) models for evaluating c-met inhibitors

被引：0
|
作者：
Chen, Dawei [1 ]
Song, Xiaoming [1 ]
Call, Jie [1 ]
Chen, Taiping [1 ]
Chen, Yiyou [1 ]
Li, Henry Q. X. [1 ]
机构：
[1] Crown Biosci, Santa Clara, CA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1322
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1322
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Paracrine c-MET/HGF HCC PDX: evaluation of a biologics targeting c -MET
    Chen, Dawei
    Sun, Ziyong
    Zhang, Likun
    Cai, Jie
    Ouyang, Davy X.
    Wery, Jean-Pierre
    Li, Henry
    [J]. CANCER RESEARCH, 2016, 76
  • [2] The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
    Varkaris, Andreas
    Corn, Paul G.
    Gaur, Sanchaika
    Dayyani, Farshid
    Logothetis, Christopher J.
    Gallick, Gary E.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (12) : 1677 - 1684
  • [3] Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models
    Gavine, Paul R.
    Ren, Yongxin
    Han, Lu
    Lu, Jing
    Fan, Shiming
    Zhang, Wei
    Xu, Wen
    Liu, Yuan Jie
    Zhang, Tianwei
    Fu, Haihua
    Yu, Yongjuan
    Wang, Huiying
    Xu, Shirlian
    Zhou, Feng
    Su, Xinying
    Yin, XiaoLu
    Xie, Liang
    Wang, Linfang
    Qing, Weiguo
    Jiao, Longxian
    Su, Weiguo
    Wang, Q. May
    [J]. MOLECULAR ONCOLOGY, 2015, 9 (01) : 323 - 333
  • [4] c-Met inhibitors
    Mughal, Anum
    Aslam, Hafiz Muhammad
    Sheikh, Asfandyar
    Khan, Agha Muhammad Hammad
    Saleem, Shafaq
    [J]. INFECTIOUS AGENTS AND CANCER, 2013, 8
  • [5] C-MET INHIBITORS
    Adjei, A. A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S22 - S22
  • [6] c-Met inhibitors
    Anum Mughal
    Hafiz Muhammad Aslam
    Asfandyar Sheikh
    Agha Muhammad Hammad Khan
    Shafaq Saleem
    [J]. Infectious Agents and Cancer, 8
  • [7] Humanisation of xenograft models to optimally assess the c-Met: HGF paracrine axis
    Kumari, R.
    Argent, R.
    Onion, D.
    Clarke, P.
    Watson, S.
    King, P.
    Page, M.
    [J]. EJC SUPPLEMENTS, 2010, 8 (07): : 88 - 88
  • [8] Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer
    Toiyama, Y.
    Tanaka, K.
    Yasuda, H.
    Saigusa, S.
    Fujikawa, H.
    Mohri, Y.
    Inoue, Y.
    Miki, C.
    Tabata, T.
    Kusunoki, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] Treatments of NSCLC-PDX with c-MET gene amplification by c-MET inhibitors lead to rapid development of drug resistance
    Yang, Mengmeng
    Song, Xiaoming
    Cai, Jie
    Wang, Youzhu
    Chen, Taiping
    Wery, Jean-Pierre
    Chen, Yiyou
    Li, Henry
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [10] Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer: Importance of Targeting c-MET and HGF Interaction
    Youngjoo Kwon
    Andrew K. Godwin
    [J]. Reproductive Sciences, 2017, 24 : 494 - 501
12345